Another investigation showed that low expression of ARHGAP6 is linked to increased metabolic activity in NSCLC, which confirms that ARHGAP6 is a potential tumor suppressor in NSCLC [316]. Here, ARHGAP6 is linked to non-small cell lung carcinoma.